Mikhail Blagosklonny is a well known oncologist and scientist who studies the effect that cancer and aging has on the human body. He attended the First Pavlov State Medical University of St. Petersburg and possesses both a M.D. in internal medicine and his PhD in experimental medicine and cardiology. Soon after graduating Blagosklonny took a job at New York Medical College as the associate professor of medicine. He has also held major positions in other prominent medical institutions including, the Ordway Research Institute and Roswell Park Cancer Institute. He has served as the Professor of Oncology at Roswell for 8 years. Being a professor came easy to Blagosklonny. He was able to draw on the information he’d gathered in past intervals of his career.
As a scientist he has come up with a hypothesis regarding TOR (target of Rapamycin) Signaling potential role in cancer and aging. Rapamycin is a drug commonly used to treat cancer. His strong belief in Rapamycin being an effective cancer drug has led to him being deemed as one of the most passionate advocates of Rapamycin for long term use. He works for Oncotarget and Cell Cycle as the editor-in-chief. He serves as the associate editor of cancer biology and therapy as well as, associate editor for PLOS ONE, the American Journal of Pathology, and International Journal of Cancer. Read more on templeofthecave.com
Blagosklonny is an author of aging hyperfunction theory. He has written and published a few hundred research articles and reviews. His subject mater includes medical treatments like cell cyclotherapy and chemotherapeutic engineering. He is adamant in his belief that aging can be controlled and cancer can be cured.
Oncologist like Mikhail Blagosklonny give hope to those suffering from cancer. If more people were as positive and driven as him the cancer might’ve been a non-lethal illness by now.